{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:17:49Z","timestamp":1784305069434,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.transci.2020.102845","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T21:38:33Z","timestamp":1591738713000},"page":"102845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-0119","authenticated-orcid":false,"given":"Ahmet","family":"Sarici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhlis Cem","family":"Ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Yokus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seniz","family":"Ongoren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Ayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sermin","family":"Altindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal Tan","family":"Koker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Faruk","family":"Kuzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7 Suppl","key":"10.1016\/j.transci.2020.102845_bib0005","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2012.04.014","article-title":"Epidemiology of myelodysplastic syndromes","volume":"125","author":"Ma","year":"2012","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.transci.2020.102845_bib0010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.1992.tb06430.x","article-title":"Age-related incidence and other epidemiological aspects of myelodysplastic syndromes","volume":"82","author":"Aul","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2020.102845_bib0015","first-page":"139","article-title":"Myelodysplastic syndrome classification","volume":"Vol. 71","author":"Ghariani","year":"2013"},{"issue":"6","key":"10.1016\/j.transci.2020.102845_bib0020","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3324\/haematol.2013.085217","article-title":"Clinical and genetic predictors of prognosis in myelodysplastic syndromes","volume":"99","author":"Bejar","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.transci.2020.102845_bib0025","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.3324\/haematol.2013.101055","article-title":"The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system","volume":"99","author":"Zipperer","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.transci.2020.102845_bib0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"1","key":"10.1016\/j.transci.2020.102845_bib0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"18","key":"10.1016\/j.transci.2020.102845_bib0040","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.1996.03540180029029","article-title":"Persons with chronic conditions - their prevalence and costs","volume":"276","author":"Hoffman","year":"1996","journal-title":"JAMA J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.transci.2020.102845_bib0045","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1200\/JCO.1998.16.4.1582","article-title":"Comorbidity and functional status are independent in older cancer patients","volume":"16","author":"Extermann","year":"1998","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.transci.2020.102845_bib0050","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<834::AID-CNCR5>3.0.CO;2-E","article-title":"Clinical symptoms and comorbidity: significance for the prognostic classification of cancer","volume":"77","author":"Piccirillo","year":"1996","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.transci.2020.102845_bib0055","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.leukres.2009.02.005","article-title":"Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes","volume":"33","author":"Wang","year":"2009","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.transci.2020.102845_bib0060","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.transci.2020.102845_bib0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000345428","article-title":"Serum ferritin is an independent prognostic factor in chinese with myelodysplastic syndromes classified as IPSS Intermediate-1","volume":"129","author":"Li","year":"2013","journal-title":"Acta Haematol"},{"issue":"23","key":"10.1016\/j.transci.2020.102845_bib0070","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.transci.2020.102845_bib0075","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3324\/haematol.2008.002063","article-title":"The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome","volume":"94","author":"Zipperer","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.transci.2020.102845_bib0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.leukres.2010.06.005","article-title":"Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients","volume":"35","author":"Breccia","year":"2011","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.transci.2020.102845_bib0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/annonc\/mdp258","article-title":"Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group","volume":"21","author":"Sperr","year":"2009","journal-title":"Ann Oncol"},{"issue":"16","key":"10.1016\/j.transci.2020.102845_bib0090","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2010.31.3353","article-title":"Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model","volume":"29","author":"Naqvi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.transci.2020.102845_bib0095","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3324\/haematol.2010.033506","article-title":"Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome","volume":"96","author":"Della Porta","year":"2011","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.transci.2020.102845_bib0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2516.2010.02435.x","article-title":"The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study","volume":"17","author":"Klamroth","year":"2011","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.transci.2020.102845_bib0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jgo.2015.05.003","article-title":"Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults","volume":"6","author":"Fega","year":"2015","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"10.1016\/j.transci.2020.102845_bib0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.1985.tb07329.x","article-title":"Myelodysplastic syndromes: a scoring system with prognostic significance","volume":"59","author":"Mufti","year":"1985","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.transci.2020.102845_bib0115","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.leukres.2012.08.005","article-title":"Prognostic scoring systems in MDS","volume":"36","author":"Germing","year":"2012","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.transci.2020.102845_bib0120","first-page":"30","volume":"9","author":"Greenberg","year":"2011","journal-title":"Myelodysplastic Syndr"},{"issue":"24","key":"10.1016\/j.transci.2020.102845_bib0125","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1182\/blood-2011-12-380162","article-title":"Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome","volume":"119","author":"Kroger","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.transci.2020.102845_bib0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/ejh.12196","article-title":"The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany","volume":"91","author":"Gattermann","year":"2013","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.transci.2020.102845_bib0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11899-013-0172-3","article-title":"There\u2019s risk, and then there\u2019s RISK: the latest clinical prognostic risk stratification models in myelodysplastic syndromes","volume":"8","author":"Zeidan","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"issue":"30","key":"10.1016\/j.transci.2020.102845_bib0140","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.transci.2020.102845_bib0145","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2010.28.3978","article-title":"Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system","volume":"29","author":"Schanz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.transci.2020.102845_bib0150","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.amjmed.2012.08.013","article-title":"Prognostication in myelodysplastic syndromes: beyond the International Prognostic Scoring System (IPSS)","volume":"126","author":"Zeidan","year":"2013","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.transci.2020.102845_bib0155","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.leu.2405070","article-title":"A prognostic score for patients with lower risk myelodysplastic syndrome","volume":"22","author":"Garcia-Manero","year":"2008","journal-title":"Leukemia"},{"issue":"27","key":"10.1016\/j.transci.2020.102845_bib0160","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2011.40.7379","article-title":"Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes","volume":"30","author":"Bejar","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220301488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220301488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:53:02Z","timestamp":1761468782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050220301488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1473050220301488"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2020.102845","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2020.102845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102845"}}